June 21 Product: argenxs Vyvgart Hytrulo Indication: Chronic inflammatory demyelinating polyneuropathy Patients with chronic inflammatory demyelinating polyneuropathy (CIDP) have a new treatment option after the FDA greenlit argenxs Vyvgart Hytrulo as the first neonatal Fc receptor (FcRn) blocker for the condition
CREB-mediated gene transcription: MAPK pathway from TrkB activation phosphorylates CREB (cAMP response element binding protein)
I benefici della Carnitina per un invecchiamento attivo Supporto alle funzioni cerebrali e Focus per il professionista La carnitina, specialmente nella sua forma acetilata (ALC), un potente neuroprotettore che oltrepassa la barriera ematoencefalica
doi: 10.1126/science.aaf1648
Age, genetics, metabolic health, and prior fertility history alter how an individual responds
Before you start, you will meet with a registered dietitian who will discuss your medical history and provide in-depth nutrition and lifestyle coaching